Big R&D Investment Trend as Mid-Cap Biotechs Push to Get Drugs to Market

11.04.2013 - Biotech firms eager to push drug candidates through clinical trials prompted an overall increase in R&D expenditure of 20% in just a year, research and consulting firm GlobalData...